Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
Recruiting
N/A
Interventional Study
Endometrial Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 42 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* • 1.Age \>18 and \<80 years old
* 2\. The pathological diagnosis was epithelial ovarian cancer
* 3.Survival time is expected to exceed 3 months
* 4.Signed consent form
Exclusion Criteria:
* 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris…
Contacts